Member Info for nootame

Lombard Medical Technologies announces new management structure London, UK, December 15, 2010 - Lombard Medical Technologies PLC (Lombard Medical or Company) (AIM: LMT), the medical device company focused on solutions for the $1 billion abdominal aortic aneurysm (AAA) repair market, today announced plans to restructure its management team to reflect the Group's mid-term strategic focus on achieving US approval and launch of the AorfixTM endovascular stent graft and further driving sales momentum in the five largest European markets. With effect from January 1, 2011, John Rush, Chief Executive Officer, will become Chairman of LMT, based principally in the U.S, and Simon Hubbert, VP of Sales and Marketing International, will become Chief Executive Officer, based in Europe. Simon Neathercoat, the current Chairman of LMT, will become Deputy Chairman. Since joining LMT in 2009, John Rush has set out clear strategic priorities for the business and achieved significant success in moving the company towards sustainable, long-term profitability, including: · Five of six FDA Pre-market Approval ("PMA") filings for Aorfix™ submitted in the U.S; final clinical module on track for submission in H1 2011 · Marketing partnership signed in Japan · Strengthening of sales and marketing team · Refocusing of sales and marketing resources on Europe's top 5 markets, to build on strong first-half sales momentum · R&D projects underway to improve the range, ease of use and cost of Aorfix™ · Reorganisation of LMT's Prestwick and Didcot operations to maximise efficiency and prepare for US launch Simon Neathercoat, Chairman of LMT, said: "Lombard Medical has made good progress over the past 15 months, creating significant positive momentum across the organisation. The change in the structure of the management team announced today will enable LMT to focus on preparing for the opportunity in the key U.S market for AorfixTM at the same time as ensuring we maximise our growing success in Europe. I am delighted that John Rush has accepted my offer of taking on the leadership of the Company as its Chairman. John's continued commitment to the business and the appointment of Simon Hubbert as CEO in charge of the day-to-day operations underline the real strengths of our leadership team as we work to build on this progress." John Rush, Chief Executive Officer of LMT, commented: "Together with the Board, I have decided that to maintain the excellent momentum and specialist expertise LMT has built up, the Company should consolidate around its existing UK operating base, which is best managed by a CEO based in Europe. Simon Hubbert has already had a major impact on our sales and marketing activities in Europe and I look forward to working with him to ensure the continued progress of Aorfix™ in the key US market." Simon Hubbert, aged 43, joined

Lombard Medical announces appointment of Dr. Peter Phillips to Board of Directors London, UK, 15 December, 2010 - Lombard Medical Technologies PLC (Lombard Medical or Company) (AIM: LMT), the medical device company focused on solutions for the $1 billion abdominal aortic aneurysm (AAA) repair market, today announced that Dr. Peter Phillips will join the Board of Directors with effect from January 1, 2011. Dr. Phillips is co-developer of the Aorfix™ Aortic Stent graft technology, the Company's principal product. He has been involved in the development and commercialisation of Aorfix™ since 1995, and is the Company's leading expert on the technology and its clinical application. In 2006, Dr. Phillips moved to the U.S where he designed and initiated the Aorfix™ Pythagoras Clinical Study, which has recently been completed. The results of the study will form part of the clinical approval package for Aorfix™, to be submitted to the U.S Food and Drug Administration (FDA) during 2011. Dr. Phillips is now back in the UK, working full time for the Company as Chief Technology Officer. Commenting on the appointment, Simon Neathercoat, Chairman of Lombard Medical, commented: "We welcome Peter's appointment which will bring significant additional technical and clinical expertise to the Board. We look forward to the valuable input he will bring to our strategic discussions as we move closer to approval of Aorfix™ in the U.S and continue to drive it's commercialisation in Europe." Dr. Phillips, 52, co-founded Anson Medical in 1995 and ran the company while it developed the Aorfix™ product range. In 2001 he sold Anson to Lombard Medical and remained Managing Director of the division until moving to the United States. He has a PhD from Guy's Hospital London, and was a director of Surgicraft, a UK orthopaedics company.

As usual it rises a bit it drops a bit.Im beginning to think the only decent rise will come once we receive some decent sales figures.

Another piece. $500 million market here we come 10% of that will do for starters.

Hi mate good to hear from you hope all is well.I think any top up at these prices is good if you have faith in the product, everything is in place so why not.Ive just released some funds and I may have a little tinker. Its a bit frustrating trying to find info on progress there just doesnt seem to be much out there.Months ago they were saying that surgeons,doctors and other professionals in the medical business were buying shares by the bucket load but I cant find any articles. I reiterate if anyone out there has any info no matter how trivial or old please post .

Loif out there by jove.

Do you ever get the impression that you are talking to yourself.

what can I say that has not been said before.I know O/T FIFA are a nice,sincere ,moralistic,honest bunch.

Red button flashing post LOL.I missed out the weekend.Come on LMT we are right behind you.

http://www.prnewswire.co.uk/cgi/news/release?id=83041 It does cost for RNS release but I didn't know the cost varied.This was posted on GKP by thetruthhurts it may answer some questions.

Hi mate when I saw the reb button flashing I got all excited.I agree with your summary and also I would like to see more news, other companies announce everything.The only thing I can think it must be down to cost it must cost something per announcement I dont know.A small company like LMT have to keep costs down and only announce what they have to. There may be someone out there to enlighten us,

Hi mate I thought full approval was nearer mid 2011.

Thanks mate very sorry to hear about your wife it must have been devastating and hope you have come out the right end too. Your imput is greatly appreciated always good to hear it from another perspective.You may be right about Q1 2011 I just think as we get closer and modules are completed it may stir up a bit more interest.We always get a little rise after good news but never sustain it but maybe in the coming months maybe we will. I have a few questions for the BOD but twice now it has failed to go through when I try to do it direct from their website and it wont allow me to do it straight via my email account.Im not great with PCs so I must be doing something wrong. Good to hear from you and keep posting.

I need set up an account maybe I will try the old fashioned route.

Im going to email the company with some questions.I tried it once before but for some reason it failed.

we seem to get small rises on news but as you can see the news doesnt come that often.FDA approval is on track in the USA one of the biggest markets for Aorfix device.LMT are currently in the process of obtaining approval of six modules of which four have been passed.Hopefull by early 2011 this should be completed with FDA approval the final piece of the jigsaw.That is a very brief overview but I would suggets reading the LMT website and RNSs for update. IMO 2p could be achievable by Q! 2011 and 5p by end of year with full US approval.The potential market is huge and Aorfix is a superb product.If they could capture just 5% of this market it is worth millions.Hope this helps. Hi New J yep Im still here with my daily post LOL.

Hi bud good tee you.I dont think there is much chance of it moving fast LOL.You are right about FDA but thats the way it is.I have searched and searched for some info on the so called professionals who have invested in these all I can find are RNSs . Ive been on the BMJ site not much on there other journal sites.I dont want to cast doubt upon the product but if its so good why cant I find much info other than whats on the LMT site?

I dont care about you but I am going to post on here at least once every day if it kills me.Even if its only to see the little red button flash.HELLO HELLo HELlo HEllo Hello hello !!!!!!!!

We need some news flow anyone know anybody connected to the medical industry or LMT even if its the Chairmans dog.LOL

I mean what a dooberry.